These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 29593020)

  • 21. Population-Attributable Fractions of Modifiable Lifestyle Factors for CKD and Mortality in Individuals With Type 2 Diabetes: A Cohort Study.
    Dunkler D; Kohl M; Teo KK; Heinze G; Dehghan M; Clase CM; Gao P; Yusuf S; Mann JF; Oberbauer R;
    Am J Kidney Dis; 2016 Jul; 68(1):29-40. PubMed ID: 26830448
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Different rates of progression and mortality in patients with chronic kidney disease at outpatient nephrology clinics across Europe.
    Brück K; Jager KJ; Zoccali C; Bello AK; Minutolo R; Ioannou K; Verbeke F; Völzke H; Arnlöv J; Leonardis D; Ferraro PM; Brenner H; Caplin B; Kalra PA; Wanner C; Castelao AM; Gorriz JL; Hallan S; Rothenbacher D; Gibertoni D; De Nicola L; Heinze G; Van Biesen W; Stel VS;
    Kidney Int; 2018 Jun; 93(6):1432-1441. PubMed ID: 29656901
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Progression of Kidney Disease in Indigenous Australians: The eGFR Follow-up Study.
    Maple-Brown LJ; Hughes JT; Ritte R; Barzi F; Hoy WE; Lawton PD; Jones GRD; Death E; Simmonds A; Sinha AK; Cherian S; Thomas MAB; McDermott R; Brown ADH; O'Dea K; Jerums G; Cass A; MacIsaac RJ
    Clin J Am Soc Nephrol; 2016 Jun; 11(6):993-1004. PubMed ID: 27076636
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Independent Role of Underlying Kidney Disease on Renal Prognosis of Patients with Chronic Kidney Disease under Nephrology Care.
    De Nicola L; Provenzano M; Chiodini P; Borrelli S; Garofalo C; Pacilio M; Liberti ME; Sagliocca A; Conte G; Minutolo R
    PLoS One; 2015; 10(5):e0127071. PubMed ID: 25992629
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Defining the contribution of chronic kidney disease to all-cause mortality in patients with type 2 diabetes: the Renal Insufficiency And Cardiovascular Events (RIACE) Italian Multicenter Study.
    Penno G; Solini A; Bonora E; Orsi E; Fondelli C; Zerbini G; Trevisan R; Vedovato M; Cavalot F; Laviola L; Nicolucci A; Pugliese G;
    Acta Diabetol; 2018 Jun; 55(6):603-612. PubMed ID: 29574497
    [TBL] [Abstract][Full Text] [Related]  

  • 26. White blood cell count predicts the odds of kidney function decline in a Chinese community-based population.
    Fan F; Jia J; Li J; Huo Y; Zhang Y
    BMC Nephrol; 2017 Jun; 18(1):190. PubMed ID: 28592280
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiovascular and all-cause mortality in patients with type 2 diabetes mellitus in the MADIABETES Cohort Study: Association with chronic kidney disease.
    Salinero-Fort MÁ; San Andrés-Rebollo FJ; de Burgos-Lunar C; Abánades-Herranz JC; Carrillo-de-Santa-Pau E; Chico-Moraleja RM; Jiménez-García R; López-de-Andrés A; Gómez-Campelo P;
    J Diabetes Complications; 2016 Mar; 30(2):227-36. PubMed ID: 26627635
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Coronary Artery Disease Is a Predictor of Progression to Dialysis in Patients With Chronic Kidney Disease, Type 2 Diabetes Mellitus, and Anemia: An Analysis of the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT).
    Sabe MA; Claggett B; Burdmann EA; Desai AS; Ivanovich P; Kewalramani R; Lewis EF; McMurray JJ; Olson KA; Parfrey P; Solomon SD; Pfeffer MA
    J Am Heart Assoc; 2016 Apr; 5(4):. PubMed ID: 27108247
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Elevated serum homocysteine is a predictor of accelerated decline in renal function and chronic kidney disease: A historical prospective study.
    Levi A; Cohen E; Levi M; Goldberg E; Garty M; Krause I
    Eur J Intern Med; 2014 Dec; 25(10):951-5. PubMed ID: 25457436
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predictors of CKD and rate of decline in eGFR in the elderly: A case-cohort study.
    Ghaffar U; Maharjan N; Moore PC
    Nephrol News Issues; 2016 Apr; 30(4):38-45. PubMed ID: 27257659
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A cohort study on the rate of progression of diabetic chronic kidney disease in different ethnic groups.
    Ali O; Mohiuddin A; Mathur R; Dreyer G; Hull S; Yaqoob MM
    BMJ Open; 2013; 3(2):. PubMed ID: 23449744
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High Baseline Levels of Tumor Necrosis Factor Receptor 1 Are Associated With Progression of Kidney Disease in Indigenous Australians With Diabetes: The eGFR Follow-up Study.
    Barr ELM; Barzi F; Hughes JT; Jerums G; Hoy WE; O'Dea K; Jones GRD; Lawton PD; Brown ADH; Thomas M; Ekinci EI; Sinha A; Cass A; MacIsaac RJ; Maple-Brown LJ
    Diabetes Care; 2018 Apr; 41(4):739-747. PubMed ID: 29367427
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Survival and Functional Stability in Chronic Kidney Disease Due to Surgical Removal of Nephrons: Importance of the New Baseline Glomerular Filtration Rate.
    Lane BR; Demirjian S; Derweesh IH; Takagi T; Zhang Z; Velet L; Ercole CE; Fergany AF; Campbell SC
    Eur Urol; 2015 Dec; 68(6):996-1003. PubMed ID: 26012710
    [TBL] [Abstract][Full Text] [Related]  

  • 34. BP and Renal Outcomes in Diabetic Kidney Disease: The Veterans Affairs Nephropathy in Diabetes Trial.
    Leehey DJ; Zhang JH; Emanuele NV; Whaley-Connell A; Palevsky PM; Reilly RF; Guarino P; Fried LF;
    Clin J Am Soc Nephrol; 2015 Dec; 10(12):2159-69. PubMed ID: 26482258
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum Bicarbonate and Kidney Disease Progression and Cardiovascular Outcome in Patients With Diabetic Nephropathy: A Post Hoc Analysis of the RENAAL (Reduction of End Points in Non-Insulin-Dependent Diabetes With the Angiotensin II Antagonist Losartan) Study and IDNT (Irbesartan Diabetic Nephropathy Trial).
    Schutte E; Lambers Heerspink HJ; Lutgers HL; Bakker SJ; Vart P; Wolffenbuttel BH; Umanath K; Lewis JB; de Zeeuw D; Gansevoort RT
    Am J Kidney Dis; 2015 Sep; 66(3):450-8. PubMed ID: 25987260
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Circulating α-klotho levels in CKD and relationship to progression.
    Kim HR; Nam BY; Kim DW; Kang MW; Han JH; Lee MJ; Shin DH; Doh FM; Koo HM; Ko KI; Kim CH; Oh HJ; Yoo TH; Kang SW; Han DS; Han SH
    Am J Kidney Dis; 2013 Jun; 61(6):899-909. PubMed ID: 23540260
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of increasing age on the prognosis of non-dialysis patients with chronic kidney disease receiving stable nephrology care.
    De Nicola L; Minutolo R; Chiodini P; Borrelli S; Zoccali C; Postorino M; Iodice C; Nappi F; Fuiano G; Gallo C; Conte G;
    Kidney Int; 2012 Aug; 82(4):482-8. PubMed ID: 22622495
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Time-dependent risk factors associated with the decline of estimated GFR in CKD patients.
    Chang WX; Arai S; Tamura Y; Kumagai T; Ota T; Shibata S; Fujigaki Y; Shen ZY; Uchida S
    Clin Exp Nephrol; 2016 Feb; 20(1):58-70. PubMed ID: 26100399
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterisation of type 2 diabetes subgroups and their association with ethnicity and clinical outcomes: a UK real-world data study using the East London Database.
    Mathur R; Hull SA; Hodgson S; Finer S
    Br J Gen Pract; 2022 Jun; 72(719):e421-e429. PubMed ID: 35577589
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Body mass index has no effect on rate of progression of chronic kidney disease in subjects with type 2 diabetes mellitus.
    Mohsen A; Brown R; Hoefield R; Kalra PA; O'Donoghue D; Middleton R; New D
    J Nephrol; 2012; 25(3):384-93. PubMed ID: 22241634
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.